bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024

Go back to bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024
(NASDAQ: BIAF) Delayed: 6.14 +0.08 (1.32%)
Previous Close $6.06    52 Week High $ 
Open $5.90    52 Week Low $ 
Day High $6.28    P/E N/A 
Day Low $5.86    EPS $ 
Volume 69,742       

(NASDAQ: BIAFW) Delayed: 0.52 -0.03 (5.45%)
Previous Close $0.55    52 Week High $ 
Open $0.54    52 Week Low $ 
Day High $0.55    P/E N/A 
Day Low $0.36    EPS $ 
Volume 1,915